Navigation Links
Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference
Date:1/12/2009

LymphoStat-B are trademarks of Human Genome Sciences, Inc.

Safe Harbor Statement

This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements are based on Human Genome Sciences' current intent, belief and expectations. These statements are not guarantees of future performance and are subject to certain risks and uncertainties that are difficult to predict. Actual results may differ materially from these forward-looking statements because of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing of clinical trials, the Company's ability to develop and commercialize products, its dependence on collaborators for services and revenue, its substantial indebtedness and lease obligations, its changing requirements and costs associated with facilities, intense competition, the uncertainty of patent and intellectual property protection, the Company's dependence on key management and key suppliers, the uncertainty of regulation of products, the impact of future alliances or transactions and other risks described in the Company's filings with the Securities and Exchange Commission. In addition, the Company will continue to face risks related to animal and human testing, to the manufacture of ABthrax and to FDA concurrence that ABthrax meets the requirements of the ABthrax contract. If the Company is unable to meet the product requirements associated with the ABthrax contract, the U.S. government will not be required to reimburse the Company for the costs incurred or to purchase any ABthrax doses. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. Human Genome Sciences undertakes no obligation to update or revise the in
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. Enrollment Begins on Human PK Study for Medidur(TM) FA
4. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
5. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
8. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
9. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
10. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... July 30, 2015  Big Cloud Analytics, Inc. ... technology, announces it is working with Intel Corporation ... the new Lockheed Martin Healthcare Technology Alliance. The ... information technology providers, medical technology companies and academic ... innovation to improve care in rapidly evolving and ...
(Date:7/30/2015)... , July 30, 2015  NanoSmart Pharmaceuticals, Inc., ... platforms, has received Orphan Drug Designation from the ... drug product that uses NanoSmart,s proprietary drug delivery ... dactinomycin for the treatment of Ewing,s sarcoma, a ... granted NanoSmart,s Orphan Drug Designation on the basis ...
(Date:7/30/2015)... /PRNewswire/ - Anything Technologies Media, Inc. (OTC:EXMT) has announced ... Solutions (FIGS), www.frontiergarden.com has been announced ... Manager for a My Compassion originated medical cannabis ... in Alaska.  The project will be funded through ... Partners. The first phase of the project, is ...
Breaking Medicine Technology:Big Cloud Analytics Develop Internet of Things (IoT) Solutions with Intel Supporting Launch of Lockheed Martin Healthcare Technology Alliance 2Big Cloud Analytics Develop Internet of Things (IoT) Solutions with Intel Supporting Launch of Lockheed Martin Healthcare Technology Alliance 3NanoSmart Receives Second FDA Orphan Drug Designation for Treatment of Pediatric Cancer 2Frontier Indoor Garden Solutions announced as Horticultural Supplier and Project Manager for Alaskan Tribal Medical Marijuana Grow Facility 2Frontier Indoor Garden Solutions announced as Horticultural Supplier and Project Manager for Alaskan Tribal Medical Marijuana Grow Facility 3
... Nov. 10, 2011 IDEV Technologies, Incorporated (IDEV), today ... company,s 6 French (6Fr) SUPERA VERITAS Transhepatic Biliary Stent ... outside the U.S. earlier this year, is the latest ... SUPERA stent, currently cleared in the U.S. for palliative ...
... Campden Publishing Ltd today launched its medical ... To coincide with the launch, Campden Health Communications has ... Reality, innovation that enables its readers to upload video ... scanning a magazine image. This is the first time ...
Cached Medicine Technology:IDEV Technologies Receives FDA Clearance for Its SUPERA VERITAS® 6 French Stent Delivery System 2Campden Publishing Unveils new Med Comms Division and World-First Technology Licence 2
(Date:7/30/2015)... Mequon, Wisconsin (PRWEB) , ... July 30, 2015 , ... ... rejuvenation. Kybella is a nonsurgical treatment designed specifically for the elimination ... is one of the first locations in the state of Wisconsin to offer this ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... Earns National Cancer Institute Designation , The Tisch Cancer Institute (TCI) at the ... Institute (NCI)-designated cancer center. TCI joins an elite group of 69 cancer institutions ...
(Date:7/30/2015)... ... 2015 , ... Author Dr. Raul Llanos seeks to empower readers ... self-help book, “ Consciously Healing our Webs of Health, Wellbeing, Success, and Abundance ” ... take responsibility for ourselves, we can create better realities.” His book illustrates the possibilities ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... ... fight with its Medicare administrative contractor (MAC) over submitted claims for bariatric surgery ... it a challenge to program integrity, Becky Dennis, a nurse auditor at WellSpan ...
(Date:7/30/2015)... UT (PRWEB) , ... July 30, 2015 , ... When trying to gain weight, many people place a lot of ... amount of calories that need to be consumed. However, another key component to successful weight ... gain weight. To assist with this, CB-1 Weight Gainer gives three tips on when ...
Breaking Medicine News(10 mins):Health News:Quintessa MedSpa Offers Nonsurgical Double-chin Elimination 2Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 2Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 3Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 4Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 5Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 6Health News:New book by Dr. Raul Llanos: ‘The power to change is within’ 2Health News:New book by Dr. Raul Llanos: ‘The power to change is within’ 3Health News:Hospital Details Fight for Bariatric Surgery Reimbursement in AIS Newsletter 2Health News:Hospital Details Fight for Bariatric Surgery Reimbursement in AIS Newsletter 3Health News:CB-1 Weight Gainer Gives Three Tips on When to Eat to Gain Weight 2Health News:CB-1 Weight Gainer Gives Three Tips on When to Eat to Gain Weight 3
... features of the anthroposophical lifestyle, such as restrictive use ... allergic disease in children// , according to a new ... Steiner developed the anthroposophic lifestyle in which health is ... followers integrate modern medicine with alternative, nature-based treatments. ...
... to be reclassified again, according to campaigners. The UK’s Advisory ... drug //is connected to mental disorders. This may result in ... years. It had been classified as a Class C substance ... the use of the drug has to be conducted, as ...
... Erdogan tried to quell fears of a pandemic by saying ... country // , is now under control. ... monitor it closely," Erdogan newsmen with visiting Japanese Prime Minister ... out of the question," he added. People identified as carriers ...
... Indians (NRI) have been called upon by Oscar Fernandes, ... to take an active part in the AIDS awareness ... the involvement of related agencies and organizations to contribute ... announcement while addressing the Panel Discussion on HIV/AIDS in ...
... winter flu in the UK is reported to be on the decline. ... every 100,000 people. This figure // has been on the decline ... reason for this is reported to be the immunity that the people ... the mutations it goes through every year. ,Most of ...
... Scientists at the University of Bonn in Germany have come up ... that a substance present in sunflowers prevents // the AIDS virus ... this would also apply to the actual disease. ,The ... a new class of AIDS drugs. But this is available in ...
Cached Medicine News:Health News:Anthroposophical Lifestyle Reduces Risk Of Allergic Disease In Children 2Health News:Turkish PM says bird flu under control 2Health News:Sunflowers Could Hold the Key to New Class of AIDS Drugs 2
... The Calypte AwareTM HIV-1/2 OMT test is ... vitro immunoassay for the,detection of antibodies to ... Type 2 (HIV-2) in human oral,mucosal transudate ... a point-of-care aid in the clinical diagnosis ...
... The OcuLight OR (532 nm) ... green product,family. The OcuLight family is ... use, and portability and it makes,up ... ophthalmic lasers. ,The OcuLight OR laser ...
...
...
Medicine Products: